NOVO.B.DK

304.6

-4.59%↓

GMAB.DK

1,950

-1.27%↓

HLUNB.DK

43.74

-0.46%↓

ZEAL.DK

523.2

-2.5%↓

NOVO.B.DK

304.6

-4.59%↓

GMAB.DK

1,950

-1.27%↓

HLUNB.DK

43.74

-0.46%↓

ZEAL.DK

523.2

-2.5%↓

NOVO.B.DK

304.6

-4.59%↓

GMAB.DK

1,950

-1.27%↓

HLUNB.DK

43.74

-0.46%↓

ZEAL.DK

523.2

-2.5%↓

NOVO.B.DK

304.6

-4.59%↓

GMAB.DK

1,950

-1.27%↓

HLUNB.DK

43.74

-0.46%↓

ZEAL.DK

523.2

-2.5%↓

NOVO.B.DK

304.6

-4.59%↓

GMAB.DK

1,950

-1.27%↓

HLUNB.DK

43.74

-0.46%↓

ZEAL.DK

523.2

-2.5%↓

Search

Coloplast A-S (Class B)

Ouvert

575 0.28

Résumé

Variation du prix de l'action

24h

Actuel

Min

572.4

Max

582.4

Chiffres clés

By Trading Economics

Revenu

-107M

805M

Ventes

28M

7B

P/E

Moyenne du Secteur

35.437

106.172

BPA

3.88

Rendement du dividende

4.01

Marge bénéficiaire

11.569

Employés

16,744

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.01%

2.31%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8B

129B

Ouverture précédente

574.72

Clôture précédente

575

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 nov. 2025, 23:07 UTC

Market Talk

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

20 nov. 2025, 22:22 UTC

Market Talk

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

20 nov. 2025, 22:08 UTC

Market Talk

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

20 nov. 2025, 21:57 UTC

Résultats

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

20 nov. 2025, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Health Care Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

20 nov. 2025, 21:31 UTC

Résultats

Nvidia's Strong Results Show AI Fears Are Premature -- Update

20 nov. 2025, 21:23 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 nov. 2025, 21:07 UTC

Résultats

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov. 2025, 21:06 UTC

Résultats

Webull 3Q Rev $156.9M >BULL

20 nov. 2025, 21:06 UTC

Résultats

Webull 3Q EPS 7c >BULL

20 nov. 2025, 21:05 UTC

Résultats

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

20 nov. 2025, 21:04 UTC

Résultats

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

20 nov. 2025, 21:04 UTC

Résultats

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

20 nov. 2025, 21:04 UTC

Résultats

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov. 2025, 21:00 UTC

Résultats

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

20 nov. 2025, 21:00 UTC

Résultats

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

20 nov. 2025, 21:00 UTC

Résultats

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

20 nov. 2025, 21:00 UTC

Résultats

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

20 nov. 2025, 21:00 UTC

Résultats

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

20 nov. 2025, 21:00 UTC

Résultats

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

20 nov. 2025, 21:00 UTC

Résultats

Intuit Backs FY26 Rev $21B-$21.19B >INTU

20 nov. 2025, 21:00 UTC

Résultats

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

20 nov. 2025, 21:00 UTC

Résultats

Intuit 1Q Consumer Rev $894M

20 nov. 2025, 21:00 UTC

Résultats

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

20 nov. 2025, 21:00 UTC

Résultats

Intuit Backs FY26 Guidance

20 nov. 2025, 21:00 UTC

Résultats

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

20 nov. 2025, 21:00 UTC

Résultats

Intuit 1Q Global Business Solutions Rev $3B

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat